The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

BACKGROUND: Alzheimer’s disease (AD) is the most commonly occurring form of dementia. It is predominantly a disease of later life, affecting 5% of those over 65 in the UK. OBJECTIVES: Review and update guidance to the NHS in England and Wales on the clinical effectiveness and cost-effectiveness of d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Health Technol Assess
Hlavní autoři: Bond, M, Rogers, G, Peters, J, Anderson, R, Hoyle, M, Miners, A, Moxham, T, Davis, S, Thokala, P, Wailoo, A, Jeffreys, M, Hyde, C
Médium: Artigo
Jazyk:Inglês
Vydáno: NIHR Journals Library 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780923/
https://ncbi.nlm.nih.gov/pubmed/22541366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta16210
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky